CNBCLean R·
Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.
Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.
Read at CNBC →
Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.
<iframe src="https://statesidedaily.com/embed/cluster/d4dc46e3bbebbee070ada400295b68855badd05f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S."></iframe>